Controversies in medical management of intracerebral hemorrhage

Canadian Journal of Neurological Sciences

Volumn 32, Issue SUPPL. 2, 2005, Pages

  Subramaniam, Suresh ^a   Hill, Michael D ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ALTEPLASE; AMINOCAPROIC ACID; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ANTIFIBRINOLYTIC AGENT; ANTIPYRETIC ANALGESIC AGENT; ANTITHROMBOCYTIC AGENT; BARBITURIC ACID DERIVATIVE; CORTICOSTEROID; COUMARIN ANTICOAGULANT; FIBRINOLYTIC AGENT; HEPARIN; HIRUDIN; INSULIN; MANNITOL; NEUROMUSCULAR BLOCKING AGENT; OXYMETAZOLINE; PHENYLEPHRINE; PHENYLPROPANOLAMINE; PROTAMINE SULFATE; PSEUDOEPHEDRINE; RECOMBINANT BLOOD CLOTTING FACTOR 7A; THROMBIN; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE; VITAMIN K GROUP;

ANTICONVULSANT THERAPY; BLOOD CLOT; BLOOD PRESSURE REGULATION; BODY TEMPERATURE; BRAIN EDEMA; BRAIN HEMATOMA; BRAIN HEMORRHAGE; BRAIN VENTRICULITIS; CLINICAL TRIAL; CONFERENCE PAPER; DISEASE CLASSIFICATION; DISEASE SEVERITY; EMERGENCY TREATMENT; EPIDEMIOLOGICAL DATA; FEVER; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPERVENTILATION; INCIDENCE; INTRACRANIAL HYPERTENSION; INTRACRANIAL PRESSURE MONITORING; MEDICAL DECISION MAKING; MENINGITIS; META ANALYSIS; MORTALITY; NEUROSURGERY; PRIORITY JOURNAL; PROGNOSIS; SEIZURE; STROKE; SYSTEMATIC REVIEW; TREATMENT INDICATION; VASCULAR AMYLOIDOSIS;

CEREBRAL HEMORRHAGE; CLINICAL TRIALS; HEMOSTATICS; HUMANS; PROGNOSIS;

EID: 31644451625     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (124)

1. Broderick JP, Brott T, Tomsick T, et al. Intracerebral hemorrhage more than twice as common as subarachnoid hemorrhage. J Neurosurg. 1993; 78(2): 188-91.
2. Mendelow AD. The International Surgical Trial in Intracerebral Haemorrhage (ISTICH). Acta Neurochir Suppl. 2003; 86: 441-3.
3. Giroud M, Milan C, Beuriat P, et al. Incidence and survival rates during a two-year period of intracerebral and subarachnoid haemorrhages, cortical infarcts, lacunes and transient ischaemic attacks. The Stroke Registry of Dijon: 1985-1989. Int J Epidemiol. 1991; 20(4): 892-9.
4. Qureshi AI, Tuhrim S, Broderick JP, et al. Spontaneous intracerebral hemorrhage. N Engl J Med. 2001; 344(19): 1450-60.
5. Bamford J, Dennis M, Sandercock P, et al. The frequency, causes and timing of death within 30 days of a first stroke: the Oxfordshire Community Stroke Project. J Neurol Neurosurg Psychiatry. 1990; 53(10): 824-9.
6. Broderick JP, Phillips SJ, Whisnant JP, et al. Incidence rates of stroke in the eighties: the end of the decline in stroke? Stroke. 1989; 20(5): 577-82.
7. Qureshi AI, Giles WH, Croft JB. Racial differences in the incidence of intracerebral hemorrhage: effects of blood pressure and education. Neurology. 1999; 52(8): 1617-21.
8. Tanaka H, Ueda Y, Hayashi M, et al. Risk factors for cerebral hemorrhage and cerebral infarction in a Japanese rural community. Stroke. 1982; 13(1): 62-73.
9. Brott T, Thalinger K, Hertzberg V. Hypertension as a risk factor for spontaneous intracerebral hemorrhage. Stroke. 1986; 17(6): 1078-83.
10. Woo D, Broderick JP. Spontaneous intracerebral hemorrhage: epidemiology and clinical presentation. Neurosurg Clin N Am. 2001; 13(3): 265-79.
11. Goldstein LB, Adams R, Becker K, et al. Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke. 2001; 32(1): 280-99.
12. Thrift AG, Donnan GA, McNeil JJ. Epidemiology of intracerebral hemorrhage. Epidemiol Rev. 1995; 17(2): 361-81.
13. Juvela S. Prevalence of risk factors in spontaneous intracerebral hemorrhage and aneurysmal subarachnoid hemorrhage. Arch Neurol. 1996; 53(8): 734-40.
14. Dandapani BK, Suzuki S, Kelley RE, et al. Relation between blood pressure and outcome in intracerebral hemorrhage. Stroke. 1995; 26(1): 21-4.
15. Meyer JS, Bauer RB. Medical treatment of spontaneous intracranial hemorrhage by the use of hypotensive drugs. Neurology. 1962; 12: 36-47.
16. He FJ, MacGregor GA. Blood pressure and stroke; the PROGRESS trial. J Renin Angiotensin Aldosterone Syst. 2001; 2(3): 153-5.
17. Perry HM Jr, Davis BR, Price TR, et al. Effect of treating isolated systolic hypertension on the risk of developing various types and subtypes of stroke: the Systolic Hypertension in the Elderly Program (SHEP). JAMA. 2000; 284(4): 465-71.
18. Sacco S, Marini C, Carolei A. Medical treatment of intracerebral hemorrhage. Neurol Sci. 2004; 25 (Suppl 1): S6-9.
19. Fisher CM. Pathological observations in hypertensive cerebral hemorrhage. J Neuropathol Exp Neurol. 1971; 30(3): 536-50.
20. Challa VR, Moody DM, Bell MA. The Charcot-Bouchard aneurysm controversy: impact of a new histologic technique. J Neuropathol Exp Neurol. 1992; 51(3): 264-71.
21. Vinters HV, Gilbert JJ. Cerebral amyloid angiopathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes. Stroke. 1983; 14(6): 924-8.
22. Vinters HV. Cerebral amyloid angiopathy. A critical review. Stroke. 1987; 18(2): 311-24.
23. Tomonaga M. Senile plaques and amyloid. Rinsho Shinkeigaku. 1982; 22(12): 1106-8.
24. Vonsattel JP, Myers RH, Hedley-Whyte ET, et al. Cerebral amyloid angiopathy without and with cerebral hemorrhages: a comparative histological study. Ann Neurol. 1991; 30(5): 637-49.
25. Hill MD, Silver FL, Austin PC, Tu JV. Rate of stroke recurrence in patients with primary intracerebral hemorrhage. Stroke. 2000; 31(1): 123-7.
26. Tanaka H, Ueda Y, Hayashi M, et al. Risk factors for cerebral hemorrhage and cerebral infarction in a Japanese rural community. Stroke. 1982; Jan-Feb;13(1):62-73.
27. Yano K, Reed DM, MacLean CJ. Serum cholesterol and hemorrhagic stroke in the Honolulu Heart Program. Stroke. 1989; 20(11): 1460-5.
28. Ueda K, Hasuo Y, Kiyohara Y, et al. Intracerebral hemorrhage in a Japanese community, Hisayama: incidence, changing pattern during long-term follow-up, and related factors. Stroke. 1988; Jan;19(1):48-52.
29. Plehn JF, Davis BR, Sacks FM, et al. Reduction of stroke incidence after myocardial infarction with pravastatin: the Cholesterol and Recurrent Events (CARE) study. The Care Investigators. Circulation. 1999; 99(2): 216-23.
30. White HD, Simes RJ, Anderson NE, et al. Pravastatin therapy and the risk of stroke. N Engl J Med. 2000; 343(5): 317-26.
31. Collins R, Armitage J, Parish S, et al. Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions. Lancet. 2004; 363(9411): 757-67.
32. Donahue RP, Abbott RD, Reed DM, Yano K. Alcohol and hemorrhagic stroke. The Honolulu Heart Program. JAMA. 1986; 255(17): 2311-4.
33. Klatsky AL, Armstrong MA, Friedman GD. Alcohol use and subsequent cerebrovascular disease hospitalizations. Stroke. 1989; 20(6): 741-6.
34. Abbott RD, Yin Y, Reed DM, Yano K. Risk of stroke in male cigarette smokers. N Engl J Med. 1986; 315(12): 717-20.
35. Juvela S. Cigarette smoking and death following subarachnoid hemorrhage. J Neurosurg. 2001; 95(4): 551-4.
36. Hart RG, Boop BS, Anderson DC. Oral anticoagulants and intracranial hemorrhage. Facts and hypotheses. Stroke. 1995; 26(8): 1471-7.
37. Thrift AG, McNeil JJ, Forbes A, Donnan GA. Risk of primary intracerebral haemorrhage associated with aspirin and nonsteroidal anti-inflammatory drugs: case-control study. Br Med J. 1999; 318(7186): 759-64.
38. Petty GW, Lennihan L, Mohr JP, et al. Complications of long-term anticoagulation. Ann Neurol. 1988; 23(6): 570-4.
39. Fogelholm R, Eskola K, Kiminkinen T, Kunnamo I. Anticoagulant treatment as a risk factor for primary intracerebral haemorrhage. J Neurol Neurosurg Psychiatry. 1992; 55(12): 1121-4.
40. Hart RG. What causes intracerebral hemorrhage during warfarin therapy? Neurology. 2000; 55(7): 907-8.
41. Smith EE, Rosand J, Knudsen KA, et al. Leukoaraiosis is associated with warfarin-related hemorrhage following ischemic stroke. Neurology. 2002; 59(2): 193-7.
42. Kernan WN, Viscoli CM, Brass LM, et al. Phenylpropanolamine and the risk of hemorrhagic stroke. N Engl J Med. 2000; 343(25): 1826-32.
43. Cantu C, Arauz A, Murillo-Bonilla LM, et al. Stroke associated with sympathomimetics contained in over-the-counter cough and cold drugs. Stroke. 2003; 34(7): 1667-72.
44. Kaku DA, Lowenstein DH. Emergence of recreational drug abuse as a major risk factor for stroke in young adults. Ann Intern Med. 1990; Dec 1;113(11):821-7.
45. Levine SR, Brust JC, Futrell N, et al. Cerebrovascular complications of the use of the "crack" form of alkaloidal cocaine. N Engl J Med. 1990; Sep 13;323(11):699-704.
46. Sloan MA, Kittner SJ, Rigamonti D, et al. Occurrence of stroke associated with use/abuse of drugs. Neurology. 1991; Sep;41(9):1358-64.
47. Daverat P, Castel JP, Dartigues JF, Orgogozo JM. Death and functional outcome after spontaneous intracerebral hemorrhage. A prospective study of 166 cases using multivariate analysis. Stroke. 1991; 22(1): 1-6.
48. Portenoy RK, Lipton RB, Berger AR, et al. Intracerebral haemorrhage: a model for the prediction of outcome. J Neurol Neurosurg Psychiatry. 1987; 50(8): 976-9.
49. Tuhrim S, Dambrosia JM, Price TR, et al. Prediction of intracerebral hemorrhage survival. Ann Neurol. 1988; 24(2): 258-63.
50. Tuhrim S, Horowitz DR, Sacher M, Godbold JH. Validation and comparison of models predicting survival following intracerebral hemorrhage. Crit Care Med. 1995; 23(5): 950-4.
51. Young WB, Lee KP, Pessin MS, et al. Prognostic significance of ventricular blood in supratentorial hemorrhage: a volumetric study. Neurology. 1990; 40(4): 616-9.
52. Broderick JP, Brott TG, Duldner JE, et al. Volume of intracerebral hemorrhage. A powerful and easy-to-use predictor of 30-day mortality. Stroke. 1993; 24(7): 987-93.
53. Douglas MA, Haerer AF. Long-term prognosis of hypertensive intracerebral hemorrhage. Stroke. 1982; 13(4): 488-91.
54. Steiner I, Gomori JM, Melamed E. The prognostic value of the CT scan in conservatively treated patients with intracerebral hematoma. Stroke. 1984; 15(2): 279-82
55. Kothari RU, Brott T, Broderick JP, et al. The ABCs of measuring intracerebral hemorrhage volumes. Stroke. 1996; 27(8): 1304-5.
56. Hemphill JC, Bonovich DC, Besmertis L. The ICH score: a simple, reliable grading scale for intracerebral hemorrhage. Stroke. 2001; 32:891-897
57. Tuhrim, S., J. M. Dambrosia, T. R. Price, et al. Intracerebral hemorrhage: external validation and extension of a model for prediction of 30-day survival. Ann Neurol. 1991; 29(6): 658-63.
58. Helweg-Larsen S, Sommer W, Strange P, et al. Prognosis for patients treated conservatively for spontaneous intracerebral hematomas. Stroke. 1984; 15(6): 1045-8.
59. Nath FP, Nicholls D, Fraser RJ. Prognosis in intracerebral haemorrhage. Acta Neurochir (Wien). 1983; 67(1-2): 29-35.
60. Gujjar AR, Deibert E, Manno EM, et al. Mechanical ventilation for ischemic stroke and intracerebral hemorrhage: indications, timing, and outcome. Neurology. 1998; 51(2): 447-51.
61. Franke CL, van Swieten JC, Algra A, van Gijn J. Prognostic factors in patients with intracerebral haematoma. J Neurol Neurosurg Psychiatry. 1992; 55(8): 653-7.
62. Herbstein DJ, Schaumberg HH. Hypertensive intracerebral hematoma. An investigation of the initial hemorrhage and rebleeding using chromium Cr 51-labeled erythrocytes. Arch Neurol. 1974; 30(5): 412-4.
63. Kazui S, Naritomi H, Yamamoto H, et al. Enlargement of spontaneous intracerebral hemorrhage. Incidence and time course. Stroke. 1996; 27(10): 1783-7.
64. Brott T, Broderick J, Kothari R, et al. Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke. 1997; 28(1): 1-5.
65. Fujii Y, Takeuchi S, Sasaki O, et al. Multivariate analysis of predictors of hematoma enlargement in spontaneous intracerebral hemorrhage. Stroke. 1998; 29(6): 1160-6.
66. Kazui S, Minematsu K, Yamamoto H, et al. Predisposing factors to enlargement of spontaneous intracerebral hematoma. Stroke. 1997; 28(12): 2370-5.
67. Ohwaki K, Yano E, Nagashima H, et al. Blood pressure management in acute intracerebral hemorrhage: relationship between elevated blood pressure and hematoma enlargement. Stroke. 2004; 35(6): 1364-7.
68. Zazulia AR, Diringer MN, Derdeyn CP, Powers WJ. Progression of mass effect after intracerebral hemorrhage. Stroke. 1999; 30(6): 1167-73.
69. Tomita H, Ito U, Ohno K, Hirakawa K. Chronological changes in brain edema induced by experimental intracerebral hematoma in cats. Acta Neurochir Suppl (Wien). 1994; 60: 558-60.
70. Enzmann DR, Britt RH, Lyons BE, et al. Natural history of experimental intracerebral hemorrhage: sonography, computed tomography and neuropathology. AJNR Am J Neuroradiol. 1981; 2(6): 517-26.
71. Xi G, Wagner KR, Keep RF, et al. Role of blood clot formation on early edema development after experimental intracerebral hemorrhage. Stroke. 1998; 29(12): 2580-6.
72. Gebel JM Jr, Jauch EC, Brott TG, et al. Natural history of perihematomal edema in patients with hyperacute spontaneous intracerebral hemorrhage. Stroke. 2002; 33(11): 2631-5.
73. Gebel, J. M., Jr., E. C. Jauch, T. G. Brott, et al. Relative edema volume is a predictor of outcome in patients with hyperacute spontaneous intracerebral hemorrhage. Stroke. 2002; 33: 2636-4.
74. Wagner KR, Xi G, Hua Y, et al. Lobar intracerebral hemorrhage model in pigs: rapid edema development in perihematomal white matter. Stroke. 1996; 27(3): 490-7.
75. Betz AL, Iannotti F, Hoff JT. Brain edema: a classification based on blood-brain barrier integrity. Cerebrovasc Brain Metab Rev. 1989; 1(2): 133-54.
76. Wagner KR, Xi G, Hua Y, et al. Lobar intracerebral hemorrhage model in pigs: rapid edema development in perihematomal white matter. Stroke. 1996; 27(3): 490-7.
77. Gebel JM, Sila CA, Sloan MA, et al. Thrombolysis-related intracranial hemorrhage: a radiographic analysis of 244 cases from the GUSTO-1 trial with clinical correlation. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. Stroke. 1998; 29(3): 563-9.
78. Lee KR, Betz AL, Kim S, et al. The role of the coagulation cascade in brain edema formation after intracerebral hemorrhage. Acta Neurochir (Wien). 1996; 138(4): 396-400; discussion 400-1.
79. Nishino A, Suzuki M, Ohtani H, et al. Thrombin may contribute to the pathophysiology of central nervous system injury. J Neurotrauma. 1993; 10(2): 167-79.
80. Vaughan PJ, Pike CJ, Cotman CW, Cunningham DD. Thrombin receptor activation protects neurons and astrocytes from cell death produced by environmental insults. J Neurosci. 1995; 15: 5389-401.
81. Striggow F, Riek M, Breder J, et al. The protease thrombin is an endogenous mediator of hippocampal neuroprotection against ischemia at low concentrations but causes degeneration at high concentrations. Proc Natl Acad Sci. 2000; USA 97(5): 2264-9.
82. Xi G, Keep RF, Hua Y, et al. Attenuation of thrombin-induced brain edema by cerebral thrombin preconditioning. Stroke. 1999; 30(6): 1247-55.
83. Broderick JP, Adams HP Jr, Barsan W, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke. 1999; 30(4): 905-15.
84. Wentworth DA, Atkinson RP. Implementation of an acute stroke program decreases hospitalization costs and length of stay. Stroke. 1996; 27(6): 1040-3.
85. Diringer MN, Edwards DF. Admission to a neurologic/neurosurgical intensive care unit is associated with reduced mortality rate after intracerebral hemorrhage. Crit Care Med. 2001; 29(3): 635-40.
86. Schellinger PD, Fiebach JB, Hoffmann K, et al. Stroke MRI in intracerebral hemorrhage: is there a perihemorrhagic penumbra? Stroke. 2003; 34: 1674-1678
87. Kidwell CS, Saver JL, Mattiello J, et al. Diffusion-perfusion MR evaluation of perihematomal injury in hyperacute intracerebral hemorrhage. Neurology. 2001; 57:1611-1617.
88. Warach S. Is there a perihematomal ischemic penumbra? More questions and an overlooked clue. Stroke. 2003; 34: 1680.
89. Siddique MS, Fernandes HM, Wooldridge TD, et al. Reversible ischemia around intracerebral hemorrhage: a single-photon emission computerized tomography study. J Neurosurg. 2002; 96: 736-741.
90. Zazulia AR, Diringer MN, Videen TO, et al. Hypoperfusion without ischemia surrounding acute intracerebral hemorrhage. J Cereb Blood Flow Metab. 2001; 21: 804-810.
91. Powers WJ, Zazulia AR, Videen TO, et al. Autoregulation of cerebral blood flow surrounding acute (6 to 22 hours) intracerebral hemorrhage. Neurology. 2001; 57: 18-24.
92. Berger AR, Lipton RB, Lesser ML, et al. Early seizures following intracerebral hemorrhage: implications for therapy. Neurology. 1988; 38(9): 1363-5.
93. Bladin CF, Alexandrov AV, Bellavance A, et al. Seizures after stroke: a prospective multicenter study. Arch Neurol. 2000; 57(11): 1617-22.
94. Faught E, Peters D, Bartolucci A, et al. Seizures after primary intracerebral hemorrhage. Neurology. 1989; 39(8): 1089-93.
95. Kilpatrick CJ, Davis SM, Tress BM, et al. Epileptic seizures in acute stroke. Arch Neurol. 1990; 47(2): 157-60.
96. Vespa PM, O'Phelan K, Shah M, et al. Acute seizures after intracerebral hemorrhage: a factor in progressive midline shift and outcome. Neurology. 2003; 60:1441-1446.
97. Song EC, Chu K, Jeong SW, et al. Hyperglycemia exacerbates brain edema and perihematomal cell death after intracerebral hemorrhage. Stroke. 2003; 34(9): 2215-20.
98. Passero S, Ciacci G, Ulivelli M. The influence of diabetes and hyperglycemia on clinical course after intracerebral hemorrhage. Neurology. 2003; 61(10): 1351-6.
99. Demchuk AM, Morgenstern LB, Krieger DW, et al. Serum glucose level and diabetes predict tissue plasminogen activator-related intracerebral hemorrhage in acute ischemic stroke. Stroke. 1999; Jan;30(1):34-9.
100. Bernard SA, Gray TW, Buist MD, et al. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med. 2002; Feb 21;346(8):557-63.
101. Hypothermia after Cardiac Arrest Study Group. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med. 2002; Feb 21;346(8):549-56.
102. MacLellan CL, Girgis J, Colbourne F. Delayed onset of prolonged hypothermia improves outcome after intracerebral hemorrhage in rats. J Cereb Blood Flow Metab. 2004; 24(4): 432-40.
103. Kawanishi M. Effect of hypothermia on brain edema formation following intracerebral hemorrhage in rats. Acta Neurochir Suppl. 2003; 86: 453-6.
104. Schwarz S, Hafner K, Aschoff A, Schwab S. Incidence and prognostic significance of fever following intracerebral hemorrhage. Neurology 2000; 54(2): 354-61.
105. Qureshi AI, Geocadin RG, Suarez JI, et al. Long-term outcome after medical reversal of transtentorial herniation in patients with supratentorial mass lesions. Crit Care Med. 2000; May; 28(5):1556-64.
106. Mayer SA, Brun NC, Begtrup K, et al. Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med. 2005; Feb 24; 352(8): 777-85.
107. Horwitz JR, Cofer BR, Warner BW, et al. A multicenter trial of 6-aminocaproic acid (Amicar) in the prevention of bleeding in infants on ECMO. J Pediatr Surg. 1998; Nov;33(11):1610-3.
108. Wilson JM, Bower LK, Fackler JC, et al. Aminocaproic acid decreases the incidence of intracranial hemorrhage and other hemorrhagic complications of ECMO. J Pediatr Surg. 1993; Apr;28(4):536-40.
109. Schaller C, Rohde V, Hassler W. Local thrombolytic treatment of spontaneous intracerebral hemorrhage with plasminogen activator (rt-PA). Indications and limits. Nervenarzt. 1995; 66(10): 792.
110. Mayfrank L, Lippitz B, Groth M, et al. Effect of recombinant tissue plasminogen activator on clot lysis and ventricular dilatation in the treatment of severe intraventricular haemorrhage. Acta Neurochir (Wien). 1993; 122(1-2): 32-8.
111. Wagner KR, Xi G, Hua Y, et al. Ultra-early clot aspiration after lysis with tissue plasminogen activator in a porcine model of intracerebral hemorrhage: edema reduction and blood-brain barrier protection. J Neurosurg. 1999; 90(3): 491-8.
112. Mohr G, Ferguson G, Khan M, et al. Intraventricular hemorrhage from ruptured aneurysm. Retrospective analysis of 91 cases. J Neurosurg. 1983; 58(4): 482-7.
113. Mayer SA, Thomas CE, Diamond BE. Asymmetry of intracranial hemodynamics as an indicator of mass effect in acute intracerebral hemorrhage. A transcranial Doppler study. Stroke. 1996; 27(10): 1788-92.
114. Coplin WM, Vinas FC, Agris JM, et al. A cohort study of the safety and feasibility of intraventricular urokinase for nonaneurysmal spontaneous intraventricular hemorrhage. Stroke. 1998; 29(8): 1573-9.
115. Naff NJ, Carhuapoma JR, Williams MA, et al. Treatment of intraventricular hemorrhage with urokinase: effects on 30-Day survival. Stroke. 2000; 31(4): 841-7.
116. Haines SJ, Lapointe M. Fibrinolytic agents in the treatment of intraventricular hemorrhage in adults Crit. Rev. Neurosurg. 1998; May 13;8(3):169-75.
117. Wang YC, Lin CW, Shen CC, et al. Tissue plasminogen activator for the treatment of intraventricular hematoma: the dose-effect relationship. J Neurol Sci. 2002; Oct 15;202(1-2):35-41.
118. Schwarz S, Schwab S, Steiner HH, Hacke W. Secondary hemorrhage after intraventricular fibrinolysis: a cautionary note: a report of two cases. Neurosurgery. 1998; 42(3): 659-62.
119. Shapiro SA, Campbell RL, Scully T. Hemorrhagic dilation of the fourth ventricle: an ominous predictor. J Neurosurg. 1994; 80(5): 805-9.
120. Rohde V, Schaller C, Hassler WE. Intraventricular recombinant tissue plasminogen activator for lysis of intraventricular haemorrhage. J Neurol Neurosurg Psychiatry. 1995; 58(4): 447-51.
121. Wilson SE, Watson HG, Crowther MA. Low-dose oral vitamin K therapy for the management of asymptomatic patients with elevated international normalized ratios: a brief review. CMAJ. 2004; 170(5): 821-4.
122. Kelly RE. Medical Therapy. In: Feldman E, editor. Intracerebral Hemorrhage. New York, Futura Publishing. 1994; P. 83-84.
123. Morgenstern LB, Demchuk AM, Kim DH, et al. Rebleeding leads to poor outcome in ultra-early craniotomy for intracerebral hemorrhage. Neurology. 2001; 56(10): 1294-9.
124. Mendelow AD, Gregson BA et al. STICH investigators. Early surgery versus initial conservative treatment in patients with spontaneous supratentoriaintracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial. Lancet. 2005; 365(9457):387-97.